Comparison of serum cytokines levels in normal-weight and overweight patients with first-episode drug-naïve major depressive disorder
Open Access
- 27 October 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 1048337
Abstract
Objective: Abnormal levels of blood cytokines have been demonstrated to be associated with both excess weight and major depressive disorder (MDD). However, few studies have addressed the direct effect of body mass index (BMI) on basal serum cytokines in individuals with first-episode drug-naïve MDD.Methods: A total of 49 patients with first-episode drug-naïve MDD were categorized into normal weight (18.5 ≤ BMI < 25 kg/m2) and overweight (25 ≤ BMI < 30 kg/m2) groups according to WHO-criteria. The severity of depressive symptoms was assessed using the 24-items Hamilton Depression Scale (HAMD-24). A total of 37 cytokines were measured using Multiplex Luminex Assays. The scores of HAMD-24 and the levels of serum cytokines between normal weight group and overweight group were compared. Multiple linear regression analysis was performed to evaluate the association between abnormal serum cytokines levels and group after adjusting for HAMD-24 scores. The correlation between BMI and the scores of HAMD-24 and the levels of serum cytokines was evaluated using Pearson correlation analysis.Results: The scores of HAMD-24 in overweight group were significantly higher than normal weight group (t = -2.930, P = 0.005). Moreover, the levels of IL-1α, IL-1RA, IL-3, CXCL10, TNF-α, and ICAM-1 in overweight patients with MDD were significantly higher than those in normal-weight patients with MDD (all P < 0.05). Furthermore, after adjustment for HAMD-24 scores, there was a significant correlation between abnormal serum cytokines levels (IL-1α, IL-1RA, IL-3, CXCL10, TNF-α, and ICAM-1) and group (all P < 0.05). Additionally, BMI was positively correlated to the serum levels of IL-1α (r = 0.428, P = 0.002), IL-3 (r = 0.529, P < 0.001), IL-6 (r = 0.285, P = 0.050), IL-10 (r = 0.423, P = 0.003), IL-12 (r = 0.367, P = 0.010), IL-15 (r = 0.300, P = 0.036), CXCL10 (r = 0.316, P = 0.030), TNF-α (r = 0.338, P = 0.021), and ICAM-1 (r = 0.440, P = 0.002) in MDD patients.Conclusions: These results provide direct evidence, probably for the first time, that overweight may be associated with several serum cytokines in patients with first-episode drug-naïve MDD. The underlying mechanisms are unclear and require further investigation.Keywords
Funding Information
- National Natural Science Foundation of China
- Key Technologies Research and Development Program of Anhui Province
This publication has 48 references indexed in Scilit:
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010
- Adipose tissue as an endocrine organMolecular and Cellular Endocrinology, 2010
- Elevated Neuroimmune Biomarkers in Sweat Patches and Plasma of Premenopausal Women with Major Depressive Disorder in Remission: The POWER StudyBiological Psychiatry, 2008
- Origin and physiological roles of inflammationNature, 2008
- Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Tumour necrosis factor‐α in human adipose tissue – from signalling mechanisms to clinical implicationsJournal of Internal Medicine, 2007
- Obesity and depressive symptoms in elderly Japanese: The Tsurugaya ProjectJournal of Psychosomatic Research, 2006
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Validity and Reliability of the Chinese Hamilton Depression Rating ScaleThe British Journal of Psychiatry, 1988